| 1 |
34907965 | Lipids and brain inflammation in APOE4-associated dementia. | 2022 Feb 1 |
1 |
| 2 |
33573174 | Eicosapentaenoic Acid Is Associated with Decreased Incidence of Alzheimer's Dementia in the Oldest Old. | 2021 Jan 30 |
1 |
| 3 |
34604280 | APOE Genotype Modifies the Plasma Oxylipin Response to Omega-3 Polyunsaturated Fatty Acid Supplementation in Healthy Individuals. | 2021 |
5 |
| 4 |
35237638 | Clinical Practice Guidelines Using GRADE and AGREE II for the Impact of Genetic Variants on Plasma Lipid/Lipoprotein/Apolipoprotein Responsiveness to Omega-3 Fatty Acids. | 2021 |
3 |
| 5 |
32690472 | Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial. | 2020 Sep |
3 |
| 6 |
28800331 | Alzheimer's Disease Biomarkers Interactively Influence Physical Activity, Mobility, and Cognition Associations in a Non-Demented Aging Population. | 2017 |
1 |
| 7 |
28855224 | DHA-rich n-3 fatty acid supplementation decreases DNA methylation in blood leukocytes: the OmegAD study. | 2017 Oct |
1 |
| 8 |
23466070 | APOE genotype modifies the association between plasma omega-3 fatty acids and plasma lipids in the Multi-Ethnic Study of Atherosclerosis (MESA). | 2013 May |
2 |
| 9 |
19748619 | Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil. | 2010 Mar |
3 |